<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Research Strategy (Approach, Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I Approach: workflow, validation plan, milestones, KPIs, and risks & mitigation."/>
  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    /* Shared header/nav (matches index.html) */
    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }

    .section{
      max-width: 1120px;
      margin: 0 auto;
      padding: 28px 20px;
    }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:flex-end; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 14px;
    }
    .doc-title{
      font-size: 1.35rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    .kicker{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin-bottom: 6px;
    }

    h2{
      font-size: 1.15rem;
      font-weight: 760;
      color:#f9fafb;
      margin: 14px 0 8px;
    }

    p{
      margin: 0 0 10px;
      font-size: .93rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns: minmax(0,1.1fr) minmax(0,1fr);
      gap:18px;
      margin-top: 10px;
      align-items:start;
    }

    .card{
      border-radius: 16px;
      padding: 14px 16px;
      background: rgba(15,23,42,0.84);
      border: 1px solid rgba(148,163,184,0.28);
      box-shadow: 0 18px 45px rgba(15,23,42,0.55);
    }

    .card h3{
      margin: 0 0 8px;
      font-size: .95rem;
      letter-spacing: .14em;
      text-transform: uppercase;
      color:#a5b4fc;
    }

    ul{
      margin: 6px 0 0;
      padding-left: 1.1rem;
      color:#d1d5db;
      font-size: .92rem;
    }
    li{ margin-bottom: 6px; }
    li strong{ color:#e5e7eb; }

    .pill-row{ display:flex; flex-wrap:wrap; gap:8px; margin-top:10px; }
    .pill{
      font-size:.72rem;
      padding: 5px 9px;
      border-radius: 999px;
      border: 1px solid rgba(129,140,248,0.45);
      background: rgba(2,6,23,0.25);
      color:#c7d2fe;
    }

    .callout{
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size: .88rem;
      color:#e5e7eb;
      margin-top: 12px;
    }
    .callout strong{ color:#22c55e; }

    .table{
      width:100%;
      border-collapse: collapse;
      margin-top: 10px;
      overflow:hidden;
      border-radius: 14px;
      border: 1px solid rgba(148,163,184,0.28);
      background: rgba(15,23,42,0.6);
    }
    .table th, .table td{
      padding: 10px 10px;
      border-bottom: 1px solid rgba(148,163,184,0.18);
      vertical-align: top;
      font-size: .88rem;
      color:#d1d5db;
    }
    .table th{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .14em;
      color:#a5b4fc;
      background: rgba(2,6,23,0.35);
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width: 920px){
      .grid-2{ grid-template-columns: minmax(0,1fr); }
    }

  /* Print friendliness */
@media print {

  /* Hide site chrome */
  header, footer { display: none !important; }

  /* Reset layout quirks that create blank space */
  .page, main, body {
    min-height: auto !important;
    height: auto !important;
  }
  main { flex: none !important; }

  /* Print colors */
  body { background:#fff !important; color:#111 !important; }
  p, li { color:#111 !important; }
  h1, h2, h3 { color:#111 !important; }
  a { color:#111 !important; text-decoration: none !important; }

  /* Remove heavy effects that can confuse pagination */
  * { box-shadow: none !important; }

  /* Page setup */
  @page { size: Letter; margin: 0.5in; }

  /* Keep print density readable (not too aggressive) */
  body { font-size: 95%; line-height: 1.32; }

  /* IMPORTANT: Allow big blocks (table/cards) to split across pages */
  table, thead, tbody, tr, td, th,
  .grid-2, .card, .callout {
    break-inside: auto !important;
    page-break-inside: auto !important;
  }

  /* Avoid ugly breaks ONLY for small headings */
  h2, h3 { break-after: avoid-page; page-break-after: avoid; }

  /* Prevent single orphan lines */
  p, li { orphans: 2; widows: 2; }

  /* Tighten spacing for print */
  .section { max-width: 100% !important; padding: 0 !important; margin: 0 0 0.18in 0 !important; }
  .topline { padding-top: 0 !important; margin-bottom: 0.12in !important; }
  .card { padding: 10px 12px !important; }
  .table th, .table td { padding: 7px 8px !important; }
}

  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html" class="active">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Research Strategy – Approach (Phase I Workflow & Validation)</h1>
        <div class="meta">
          PromptGenix LLC &middot; Contact: dohoon.kim1@icloud.com &middot; promptgenix.org
        </div>
      </div>

      <div class="kicker">Phase I goal</div>
      <h2>Build a validated, reproducible prototype that produces pipeline results and ranked hypotheses from public datasets.</h2>
      <p>
        Phase I focuses on engineering robustness, reproducibility, and measurable performance gains.
        Validation will rely exclusively on public datasets (e.g., GEO/SRA for RNA-Seq and FlowRepository for flow cytometry),
        minimizing IP or data-use conflicts while enabling transparent evaluation.
      </p>

      <div class="grid-2">
        <div class="card">
          <h3>Workflow overview</h3>
          <ul>
            <li><strong>Inputs:</strong> FASTQ (bulk or single-cell), FCS files, or public accession IDs.</li>
            <li><strong>Automated pipelines:</strong> QC → preprocessing → analysis (DEG, signatures, enrichment / gating / subsets).</li>
            <li><strong>Outputs:</strong> versioned results + reviewer-ready HTML/PDF report + structured artifacts for reuse.</li>
            <li><strong>LLM layer:</strong> converts results into mechanistic narratives under strict traceability constraints, requiring explicit linkage to observed pipeline outputs and cited literature.</li>
          </ul>
          <div class="pill-row">
            <span class="pill">Reproducible configs</span>
            <span class="pill">Versioned outputs</span>
            <span class="pill">HTML/PDF reports</span>
            <span class="pill">Traceable citations</span>
          </div>
        </div>

        <div class="card">
          <h3>Hypothesis Generator (traceable)</h3>
          <p>
            The Hypothesis Generator is designed to produce <strong>testable</strong> and <strong>ranked</strong> hypotheses
            grounded in literature-aware reasoning.
          </p>
          <ul>
            <li><strong>Evidence stitching:</strong> connect observed signals (DE genes, pathways, immune subsets) to plausible mechanisms.</li>
            <li><strong>Ranking:</strong> prioritize by consistency with dataset signals, coherence with known biology, and actionability.</li>
            <li><strong>Experiments:</strong> recommend concrete next steps (flow panels, contrasts, subset analyses, validation assays).</li>
            <li><strong>Traceability:</strong> include PubMed-style citations and “why this hypothesis” rationale for reviewer transparency.</li>
          </ul>
          <div class="callout">
            <strong>Phase I emphasis:</strong> traceable reasoning over “black-box” generation.
          </div>
        </div>
      </div>

      <div class="kicker" style="margin-top:18px;">Phase I validation plan</div>
      <h2>Public-data evaluation with measurable KPIs.</h2>

      <table class="table" aria-label="Phase I validation plan table">
        <thead>
          <tr>
            <th style="width:18%;">Work package</th>
            <th style="width:52%;">What we will do</th>
            <th style="width:30%;">Success metrics (examples)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>WP1</strong><br/>Pipelines</td>
            <td>
              Harden automated RNA-Seq and flow cytometry pipelines across multiple public datasets.
              Standardize configuration, logging, and export formats to enable deterministic reruns.
            </td>
            <td>
              ≥90% reproducibility across reruns (same inputs/configs).<br/>
              ≥70% reduction in turnaround time vs. manual workflow baseline.
            </td>
          </tr>
          <tr>
            <td><strong>WP2</strong><br/>Hypotheses</td>
            <td>
              Implement Hypothesis Generator producing ranked hypotheses with supporting evidence from pipeline outputs
              and traceable literature-aware citations.
            </td>
            <td>
              ≥80% “useful” rating by pilot users, defined as hypotheses that directly inform at least one concrete follow-up analysis or experimental decision.<br/>
              Clear traceability: each hypothesis includes evidence + citations.
            </td>
          </tr>
          <tr>
            <td><strong>WP3</strong><br/>Reports</td>
            <td>
              Generate reviewer-ready HTML/PDF outputs (figures, tables, narrative, hypotheses, experiment plan).
              Improve readability and reduce manual post-processing.
            </td>
            <td>
              Report generated within &lt;24 hours from raw inputs (dataset-dependent).<br/>
              Reduced manual editing time (tracked in pilot feedback).
            </td>
          </tr>
        </tbody>
      </table>

      <div class="callout">
        <strong>Data-use boundary:</strong> Phase I evaluation uses public datasets only (GEO/SRA/FlowRepository),
        enabling clean SBIR review and minimizing IP concerns.
      </div>

      <div class="kicker" style="margin-top:18px;">Risks &amp; Mitigation</div>
      <h2>Practical risks addressed with explicit fallback strategies.</h2>

      <div class="grid-2">
        <div class="card">
          <h3>Technical risks</h3>
          <ul>
            <li><strong>Dataset heterogeneity:</strong> inconsistent metadata / formats across repositories.</li>
            <li><strong>Compute variability:</strong> differences between local Mac Studio and cloud environments.</li>
            <li><strong>Model drift / hallucinations:</strong> LLM may overstate evidence without guardrails.</li>
          </ul>
        </div>

        <div class="card">
          <h3>Mitigation strategies</h3>
          <ul>
            <li><strong>Robust ingest layer:</strong> schema detection + validation + standardized output templates.</li>
            <li><strong>Deterministic runs:</strong> pinned versions, config snapshots, and re-run checksums.</li>
            <li><strong>Traceability guardrails:</strong> require citations/evidence per hypothesis; label uncertainty explicitly.</li>
            <li><strong>Fallback mode:</strong> if citations are weak, generate “candidate hypotheses” with a clear confidence flag and recommended data needs.</li>
          </ul>
        </div>
      </div>

      <div class="callout">
        <strong>Reviewer-friendly principle:</strong> Every claim must be traceable to (1) observed data outputs or (2) cited literature,
        with uncertainty explicitly stated.
      </div>
    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
